Article
Adenovirus-mediated interleukin-18 mutant in vivo gene transfer inhibits tumor growth through the induction of T cell immunity and activation of natural killer cell cytotoxicity.
Cancer gene therapy - 1 Jun 2004
Hwang Kyung-Sun, Cho Won-Kyung, Yoo Jinsang, Seong Young Rim, Kim Bum-Kyeng, Kim Samyong, Im Dong-Soo
Abstract excerpt
We report here that gene transfer using recombinant adenoviruses encoding interleukin (IL)-18 mutants induces potent antitumor activity in vivo. The precursor form of IL-18 (ProIL-18) is processed by caspase-1 to produce bioactive IL-18, but its cleavage by caspase-3 (CPP32) produces an inactive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
